EU public health guidelines announced as adapted Covid-19 vaccines authorised for use

Adapted versions of the original vaccines Comirnaty (Pfizer/BioNTech) and Spikevax (Moderna) were authorised for use across the EU on September 1 to target the Omicron BA.1 subvariant in addition to the original strain of Covid-19. File picture: Rogelio V Solis/AP

The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have provided updated public health recommendations on the use of newly authorised adapted Covid-19 vaccines.

The recommendations come as the adapted versions of the original vaccines Comirnaty (Pfizer/BioNTech) and Spikevax (Moderna) were authorised for use across the EU on September 1 to target the Omicron BA.1 subvariant in addition to the original strain of Covid-19.